Medgend Icon







discontinued


Search instead for ethics

Bethkis FDA Approved Drugs

AKTOB [TobramycinC18H37N5O9]
RX
-
0.3% (ophthalmic solution/drops)
AkornJan 31, 1996
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

BETHKIS [TobramycinC18H37N5O9]
RX
-
300mg/4ml (inhalation solution)
Chiesi Usa IncOct 12, 2012
  • Management of cystic fibrosis patients.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KITABIS PAK [TobramycinC18H37N5O9]
RX
-
300mg/5ml (inhalation solution)
Pulmoflow IncDec 2, 2014
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TOBI [TobramycinC18H37N5O9]
RX
-
300mg/5ml (inhalation solution)
Novartis PharmsDec 22, 1997
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TOBI PODHALER [TobramycinC18H37N5O9]
RX
-
28mg (inhalation powder)
NovartisMar 22, 2013
  • Treatment of cystic fibrosis patients with pseudomonas aeruginosa.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TOBRAMYCIN [TobramycinC18H37N5O9]
RX
-
0.3% (ophthalmic solution/drops)
300mg/5ml (inhalation solution)
Bausch And LombNov 29, 1993
Fera PharmsSep 11, 2001
Somerset Theraps LlcJun 28, 2017
Akorn IncMay 28, 2014
Amneal PharmsJul 13, 2015
Lupin AtlantisMar 22, 2017
Teva Pharms UsaOct 10, 2013
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TOBREX [TobramycinC18H37N5O9]
RX
-
0.3% (ophthalmic solution/drops)
Novartis Pharms CorpApproved Prior To Jan 1, 1982
Sandoz IncDec 13, 1984
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.